As with all medical interventions, PT-141 should be administered only under professional supervision to ensure optimal results, safety, and accurate dosage
Kidney damage, typically resulting from dehydration caused by other side effects A potential risk of thyroid cancer animal studies have shown an increased risk for thyroid C-cell tumors, though that risk has not yet been confirmed in humans
But certain presentations consistently produce faster, more dramatic before and after outcomes
Additionally, efpeglenatide significantly improved blood sugar levels and lipid profiles
Accessed December 16, 2025
Common research protocols use 1-3 mg daily via subcutaneous injection